News

BIOTHERAPY SERVICES AWARDED INNOVATION PASSPORT FOR GROUNDBREAKING TREATMENT FOR DIABETIC FOOT ULCERS.  WINDSOR, April 8, 2021 – Biotherapy Services Ltd (BTS), a clinical stage pharmaceutical biotechnology company developing novel autologous therapies for complex and chronic wounds, has been awarded the innovative medicine designation – the Innovation...

Biotherapy Services Ltd. welcome Jo Briggs to the team. Joanne Briggs is joining BTS as our new Senior Specialist Consultant. Biotherapy Services Ltd are an established Clinical-Pharmaceutical-Biotech company providing specialist point of care technology and  regenerative services to Specialist surgeons, using autologous biologics and treatments which are...

Specialist Mobile Wound Healing Clinic Goes on the Road to Provide Revolutionary New Treatments   In a unique collaboration between award-winning Harley Street Skin clinic and Biotherapy Services Ltd., a state of the art mobile wound clinic will be on the road from October 5th. The first of...

The Stem for Britain programme is one of the most exciting platforms for the development and discovery of young talent in the  disciplines of science, technology, engineering and mathematics, and we salute each of you as participants, finalists, award winners and future ‘game changers’!   The timing...

At Biotherapy Services we are hugely excited by the proposal of the Medicines and Medical Device Bill introduced on 13/02/2020. Without this support of the UK Government, we would be unable to develop innovative point of care manufactured medicines providing important new treatment options for the people of...

Innovative biopharmaceutical company Biotherapy Services Ltd secures £3.0 million investment from Foresight £3.0 million investment from Foresight VCT and Foresight 4 VCT. Biotherapy Services Limited has developed a pioneering treatment for complex wounds and the product is in clinical trials for the treatment of diabetic...

Biotherapy Services appoints John Chiplin as Chairman We are pleased to announce the key appointment to the BTS Board of Dr John Chiplin PhD as Chairman. John is Managing Director of Newstar Ventures Ltd. and also Chairman of Scancell Holdings plc (LSE:SCLP) and has extensive UK...

8thMarch 2019   Biotherapy Services Limited Exciting Update RAPID-1 Diabetic Foot Ulcer [RAPID-1DFU] Randomised Controlled Trial   The Board and Executive Management Team are delighted to announce that the treatment of patients has commenced on the RAPID-1DFU trial. The RAPID Biodynamic Haematogel treatment is the first-in-class, medicinal product under development for the...

    Biotherapy Services Limited   MHRA approves the RAPID-1DFU clinical trial  Company is progressing as planned towards Q1/2019 clinical trials. 8thNovember 2018, Biotherapy Services Ltd. the specialist wound healing service company, today announces that it has secured regulatory approval from the Medicines and Healthcare Regulatory Agency (MHRA) for the commencement...